NPPB and bronchopulmonary dysplasia: In a retrospective analysis from a randomized controlled trial by Potsiurko et al., the markers of hsPDA, that is, the serum NT-proBNP concentration and diameter of PDA, were found to be significant indicators in the first days of life for the development of BPD or death at 36 weeks PMA.